Trial
NCT04815967
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC
Collaborators
—
Condition
Spasticity
Intervention
Phase 2
Why stopped
Company/sponsor business decision; not due to or related to any safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-27